Particle.news

Download on the App Store

Restoring Mitochondrial Protease LONP1 Reverses β-Cell Failure in Type 2 Diabetes Models

This finding opens a path to therapies that enhance mitochondrial protein quality control

Image

Overview

  • Mitochondria in type 2 diabetic β-cells accumulate misfolded proteins because LONP1 levels are markedly reduced
  • University of Michigan researchers confirmed that LONP1 activity fails to engage defense systems against damaged mitochondrial proteins in diabetic islet cells
  • Mice lacking LONP1 develop hyperglycemia and lose pancreatic β-cells, and reintroducing LONP1 restores normal glucose regulation and cell survival
  • The study shifts the focus of β-cell failure from endoplasmic reticulum stress to mitochondrial protein-folding defects as a key driver of cell death
  • The team plans to screen for compounds that boost mitochondrial protein refolding or clearance as potential new treatments for type 2 diabetes